Metheptazine is an opioid analgesic from the phenazepane family. It was developed by American Home Products in the 1950s.[1]
Clinical data | |
---|---|
Other names | Metheptazine |
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
ChEMBL |
|
Chemical and physical data | |
Formula | C16H23NO2 |
Molar mass | 261.365 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(what is this?) (verify) |
Metheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.
Metheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States.[2] The Canadian Controlled Drugs and Substances Act specifically excludes the phenazepine opioids from control.